DREAM reliably reminds patients in 23 countries worldwide to take their medication and attend vaccination appointments British biopharmaceutical company GSK is relying on the expertise of IT service ...

GSK has partnered with IT services provider adesso to develop DREAM (Digital Reminders for Adherence of Medicines and Vaccines), a digital solution designed to help patients stay on track with ...

Two new antibiotics offer hope for people with gonorrhoea that is resistant to currently available drugs. Yet, it might be years before the people who need these medicines can get them. Spotlight ...

Nasal Sprays Market Nasal Sprays Market Shows Strong Potential Amid Health Awareness The nasal sprays market is evolving fast, driv ...

Perimeter Medical Imaging AI, Inc. ("Perimeter" or the "Company") announced today that it has launched the OCT-Tissue Surveillance Registry, a database that aims to collect thousands of images and ...

Or, perhaps more diplomatically, an 'escalate to de-escalate' strategy." He continued: "Every tariff threat takes another chunk out of the US' institutional credibility, and provides international ...

At GSK's Global Health R&D lab in Tres Cantos ... for uptake by mosquito contact, thereby breaking the transmission cycle of malaria. Source. We are a global biopharma company with a purpose ...

An Irvine man who offered a £35,000 reward for the return of his missing therapy dog has been given some hope after a potential sighting in ...

Mumbai: GlaxoSmithKline Pharmaceuticals Limited has announced the appointment of Chinmay Sharma, Executive Vice President - ...

London: GSK plc has announced the New Drug Application (NDA) for linerixibat, an investigational targeted inhibitor of the ...

In pharmaphorum's Digital and social media themed month, Daniel Ghinn explores GSK's use of social media and the milestones it has reached to achieve its current success in this space. "There's a ...

GlaxoSmithKline chief executive Emma Walmsley was no doubt hoping that an upbeat assessment of the firm's prospects at an investor meeting last week would deflect criticism of her leadership from ...